Heidi shifting from documentation to agentic clinical action
1 Sep 22 · 4d ago · 2 articles · 1 source · development 1 of 1
CEO Dr. Thomas Kelly outlined ambition to move beyond note-writing toward 'agentic capabilities' where AI completes clinical work under clinician supervision. Funds include investment in clinical evidence, quality management systems, and regulatory submissions required for healthcare AI.
“From the day I started Heidi, the ambition was always bigger than writing doctors' notes. That's the shift we're now making: from documenting care to helping clinicians act on it.”
Dr. Thomas KellyDr. Thomas Kelly Co-founder and CEO of HeidiBlackbird Lead investor, Series CGeneral Catalyst (Customer Value Fund) Growth investment leadHeidi AI care partner platform
The whole story articles the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by DealStreetAsia, 4d ago · also FinSMEs
1 more headline
- Heidi Raises $100M in Series C Funding FinSMEs · 4d ago
All 1 developments of Heidi raises $100M Series C at $900M valuation, adds $240M… →
Newswires